This finding indicated that CCR8 blockade or depletion antibody may be used for the clinical treatment of a variety of cancers, including colorectal cancer, whether it is used as a monotherapy or in combination with other immunotherapies [28]. Here, CCR8 is linked to colorectal cancer.